Wordt geladen...
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
The advent of immunotherapy, especially checkpoint inhibitor-based immunotherapy, has provided novel and powerful weapons against cancer. Because only a subset of cancer patients exhibit durable responses, further exploration of the mechanisms underlying the resistance to immunotherapy in the bulk o...
Bewaard in:
| Gepubliceerd in: | J Hematol Oncol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6389077/ https://ncbi.nlm.nih.gov/pubmed/29482595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0578-4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|